Reference
- Longinetti E, Fang F. Curr Opin Neurol. 2019;32(5):771–76.
References
- de Boer EMJ, Barritt AW, Elamin M et al. Neurol Clin Pract. 2021;11:147–57.
- Vucic S, Tian D, Chong PS et al. Brain. 2006;129:3384–90.
References
- Feldman EL, Goutman SA, Petri S, et al. Amyotrophic lateral sclerosis. Lancet. 2022;400:1363–1380.
- Chiò A, Mora G, Moglia C, et al. Secular trends of amyotrophic lateral sclerosis: The Piemonte and Valle d’Aosta Register. JAMA Neurol. 2017;74(9):1097–1104.
References
- MackenzieIRA. Neuropathology of primary lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21(sup1):47–51.
- MackenzieIRA, BriembergH. TDP-43 pathology in primary lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21(sup1):52–8.
References
- Nakayama Y, Shimizu T, Mochizuki Y, et al. Predictors of impaired communication in amyotrophic lateral sclerosis patients with tracheostomy-invasive ventilation. ALSFTLD 2015 amyotrophic lateral sclerosis and frontotemporal degeneration. 2016;17(1–2):38–46.
- Nakayama Y, Shimizu T, et al. Non-motor manifestations in ALS patients with tracheostomy and invasive ventilation. Muscle Nerve. 2018:57:735–41.